Yolande Chen is an Oncology physician affiliated with University of Illinois Chicago. OpenAlex indexes 23 publications with 300 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tempus AI, IncProgram year20242 payments
- Intera Oncology, IncProgram year20241 payment
- PFIZER INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
26.2%Phenothiazine16.7%Prochlorperazine Maleate100%Part D≥13 patientsGabapentinoids9.5%Gabapentin100%Part D<11 patientsMetabolism & gastrointestinal
24.6%Opioid Agonist15.9%Loperamide100%Part D<11 patientsAntidiarrheal microorganisms8.7%Zenpep100%Part D<11 patientsSensory organs
19%Corticosteroid19%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2015–2019 per NIH RePORTER. The latest:
- Membrane-Cytoskeletal Remodeling in Platelet Biogenesis
Northwestern University at Chicago
FY2019$77,780K08HL114871 - MEMBRANE-CYTOSKELETAL REMODELING IN PLATELET BIOGENESIS
University of Illinois at Chicago
FY2019$26,419K08HL114871 - Membrane-Cytoskeletal Remodeling in Platelet Biogenesis
Northwestern University at Chicago
FY2018$103,130K08HL114871
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Stereotactic Body Radiation Therapy Facilitating Debulking Surgery in Metastatic VIPoma with Severe Diarrhea and Hypovolemic Shock
American Journal of Case Reports
2025 - Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report
World Journal of Clinical Cases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Jerry Krishnan, MD
University of Illinois Chicago
John Daugirdas, MD
University of Illinois Chicago
Niranjan Karnik, MD
University of Illinois Chicago
Oana Danciu, MD
University of Illinois Chicago
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”